National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
January 26, 2010 • Volume 7 / Number 2


NCRR Hosts CTSA Industry Forum to Promote Collaboration, Drug Development

On February 17 and 18, the National Center for Research Resources (NCRR) will present the Clinical and Translational Science Award (CTSA) Industry Forum: “Promoting Efficient and Effective Collaborations among Academia, Government, and Industry.” Designed to explore ways to streamline the development of new drugs, devices, and diagnostics, the forum will focus on current practices and successful management models to improve this process.

NIH Director Dr. Francis Collins will deliver the opening address entitled, “Why Industry and Academia Should Work Together: An NIH Perspective,” and NCI Deputy Director Anna Barker will serve on a panel to discuss opportunities and unmet needs in translational research. Sessions will focus on translational research topics, challenges, and potential solutions; issues and barriers to intervention development; innovative new models, and international perspectives.

The forum will take place on the NIH main campus and will be videocast online. The event is free and open to the public. Posters are due by February 1, and registration is requested by February 5. To register or submit a poster, visit the forum Web site.

Registration Open for Cancer Drug Development Meeting

TAT 2010

On March 4–6, NDDO Education Foundation, NCI, and the European Society for Medical Oncology will co-sponsor “TAT 2010: 8th International Symposium on Targeted Anticancer Therapies” in Bethesda, MD.

The all-plenary program will include keynote presentations, reviews, and original papers on emerging targeted agents for cancer therapy, with updates on early phase clinical studies, preclinical studies, and translational research. 

Program topics include:

  • Insulin-like growth factor receptor inhibitors
  • RNA-based approaches to cancer treatment
  • Targeting the cancer stem cell
  • DNA repair mechanisms as drug targets
  • Other drug targets in clinical development
  • Drug development methodology and regulatory affairs

The program is designed to offer ample opportunity for interaction and discussion with leading experts, and participants may earn continuing medical education credits.

View the final program and register online by February 28.

NCI Holds Annual Intramural Scientific Retreat

On January 7, NCI’s Annual Intramural Scientific Retreat brought together investigators from NCI’s Center for Cancer Research (CCR) and Division of Cancer Epidemiology and Genetics (DCEG), as well as members of NCI’s Board of Scientific Counselors, Board of Scientific Advisors, and the National Cancer Advisory Board. The event provided an opportunity for colleagues from different disciplines to interact and learn about the work being done across the institute.

Over the course of the day, three award lectures were presented. Dr. Michael Gottesman presented on “New Ways to Think about Multidrug Resistance in Cancer” for the Alan S. Rabson Award Lecture for Intramural Research, Dr. Leslie Bernstein delivered the NCI Rosalind E. Franklin Award Lecture for Women in Cancer Research on “Reducing Breast Cancer Risk through Biology, Epidemiology, and Serendipity,” and Dr. Stephen Baylin spoke about “Dissecting the Cancer Epigenome—From Biology to the Patient” for the Alfred G. Knudson Award Lecture in Cancer Genetics.

The Women Scientists’ Association (WSA) hosted a lunchtime discussion on topics related to career development in science. The first WSA Mentoring and Leadership Awards were presented to DCEG’s Dr. Joseph Fraumeni and CCR’s Dr. Maria Merino.

Finally, a number of NCI scientists received NCI Director’s Intramural Innovation Awards, which are designed to support the development of highly innovative approaches and technologies that could unravel cancer-related problems.

Recipients of NCI Director's Intramural Innovation Awards Recipients of NCI Director's Intramural Innovation Awards

New NCI Spanish-language Resources Available

NCI Spanish-language booklets from the What You Need to Know About Cancer series

NCI has released three new Spanish-language materials that are part of the popular What You Need To Know (WYNTK) About Cancer series: 

WYNTK booklets are intended for recently diagnosed cancer patients to help them prepare for treatment.  Nine WYNTK topics are now available in Spanish on